a group of seasoned biopharma entrepreneurs, executives, and scientists
with proven track records of success on a global scale
Dr. Yixin (Jim) Wang has more than 30 years of biomedical R&D experience, including early development and identification of targets, R&D, screening and characterization of macromolecular and small molecule drugs, IND and clinical phase I&II trials. Prior to joining Innoland, he served as the President, International Institute of Biomedical Research, Senior Vice President, CVMD Research of Crown Bioscience, returned to China in 2010 and set up the CVMD department with remarkable achievements. Before that, he worked in several major pharmas and biotech such as GSK, Roche, Berlex and Bayer. Dr. Wang graduated from Fudan University Shanghai Medical College, started his career as a postdoctoral researcher in Boston University, later as an assistant professor in University of Tennessee at Memphis. He has made important achievements in the field of cardiovascular physiology and pharmacology. he has published over 100 peer-reviewed research articles, invited reviewers, book chapters, patent applications, etc.